Candida vulvovaginitis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Dima Nimri (talk | contribs) No edit summary |
Dima Nimri (talk | contribs) No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Candida]] [[vulvovaginitis]] is not a reportable disease and epidemiological studies on the prevalence of the disease are hard to perform. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Epidemiological studies on [[Candida]] [[vulvovaginitis]] are hard to perform, because of several factors:<ref name="pmid9500475">{{cite journal |vauthors=Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, Reed BD, Summers PR |title=Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations |journal=Am. J. Obstet. Gynecol. |volume=178 |issue=2 |pages=203–11 |year=1998 |pmid=9500475 |doi= |url=}}</ref><ref name="pmid17560449">{{cite journal |vauthors=Sobel JD |title=Vulvovaginal candidosis |journal=Lancet |volume=369 |issue=9577 |pages=1961–71 |year=2007 |pmid=17560449 |doi=10.1016/S0140-6736(07)60917-9 |url=}}</ref> | |||
1. [[Candida]] [[vulvovaginitis]] is not a reportable disease | |||
2. The diagnosis of [[Candida]] [[vulvovaginitis]] is based on clinical presentation, as well as positive laboratory findings. Relying on a positive culture alone would likely overestimate the prevalence of [[Candida]] [[vulvovaginitis]] | |||
3. The use of over-the-counter (OTC) topical anti-fungals makes epidemiological studies harder to perform | |||
==References== | ==References== | ||
Revision as of 21:50, 18 October 2016
|
Candidiasis Main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]
Overview
Candida vulvovaginitis is not a reportable disease and epidemiological studies on the prevalence of the disease are hard to perform.
Epidemiology and Demographics
Epidemiological studies on Candida vulvovaginitis are hard to perform, because of several factors:[1][2] 1. Candida vulvovaginitis is not a reportable disease 2. The diagnosis of Candida vulvovaginitis is based on clinical presentation, as well as positive laboratory findings. Relying on a positive culture alone would likely overestimate the prevalence of Candida vulvovaginitis 3. The use of over-the-counter (OTC) topical anti-fungals makes epidemiological studies harder to perform
References
- ↑ Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, Reed BD, Summers PR (1998). "Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations". Am. J. Obstet. Gynecol. 178 (2): 203–11. PMID 9500475.
- ↑ Sobel JD (2007). "Vulvovaginal candidosis". Lancet. 369 (9577): 1961–71. doi:10.1016/S0140-6736(07)60917-9. PMID 17560449.